Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

KOSP

Kos (KOSP)

Kos Pharmaceuticals

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:KOSP

1 2 3 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
13/12/2006	15h22	PR Newswire (US)	Abbott Acquires a Majority of Shares of Kos Pharmaceuticals, Inc.	NASDAQ:KOSP	Kos Pharmaceuticals
04/12/2006	21h36	PR Newswire (US)	Abbott's Acquisition of Kos Pharmaceuticals, Inc. Clears Antitrust Review	NASDAQ:KOSP	Kos Pharmaceuticals
14/11/2006	19h45	PR Newswire (US)	Abbott Laboratories Commences Tender Offer for All Outstanding Shares of Kos Pharmaceuticals, Inc.	NASDAQ:KOSP	Kos Pharmaceuticals
09/11/2006	13h00	Business Wire	Kos Reports a 17% Increase in Revenue, Earnings Per Share of $0.71, and Solid Cash Flow from Operations	NASDAQ:KOSP	Kos Pharmaceuticals
07/11/2006	17h21	PR Newswire (US)	Holland & Knight Leads Kos Pharmaceuticals, Inc. Buyout by Abbott Laboratories for $3.7 Billion	NASDAQ:KOSP	Kos Pharmaceuticals
06/11/2006	13h50	PR Newswire (US)	Abbott to Expand Presence in Lipid Management Market With Acquisition of Kos Pharmaceuticals	NASDAQ:KOSP	Kos Pharmaceuticals
03/11/2006	15h31	Business Wire	Kos to Report Third Quarter Results on November 9, 2006 Conference Call at 8:30 A.M. ET	NASDAQ:KOSP	Kos Pharmaceuticals
21/09/2006	22h41	Business Wire	Kos Announces Positive Overall Results for Two Phase III Trials of Icatibant for the Treatment of Hereditary Angioedema	NASDAQ:KOSP	Kos Pharmaceuticals
19/09/2006	13h00	Business Wire	Kos to Present at the UBS Global Life Sciences Conference	NASDAQ:KOSP	Kos Pharmaceuticals
18/09/2006	16h05	Business Wire	Kos Pharmaceuticals Announces Compliance with NASDAQ Continued Listing Requirements	NASDAQ:KOSP	Kos Pharmaceuticals
06/09/2006	14h30	PR Newswire (US)	SkyePharma and Mundipharma Announce Exclusive Licence Agreement for Marketing and Distribution of Flutiform(TM) in Europe	NASDAQ:KOSP	Kos Pharmaceuticals
16/08/2006	22h15	Business Wire	Kos Announces Notice from Nasdaq Regarding Potential Delisting	NASDAQ:KOSP	Kos Pharmaceuticals
09/08/2006	18h42	PR Newswire (US)	Arisaph Pharmaceuticals Announces Second Closing of $8 Million Equity Investment	NASDAQ:KOSP	Kos Pharmaceuticals
08/08/2006	13h00	Business Wire	Kos Reports 25% Increase in Revenue, Solid Financial Results and Progress in Research and Development	NASDAQ:KOSP	Kos Pharmaceuticals
27/07/2006	16h26	Business Wire	Kos to Report Second Quarter Results on August 8, 2006 Conference Call at 8:30 a.m. ET	NASDAQ:KOSP	Kos Pharmaceuticals
25/07/2006	16h39	Business Wire	Kos Reports Summary Results from Clinical Study on Benefits of Combining Aspirin with Optimized Niaspan(R) CF	NASDAQ:KOSP	Kos Pharmaceuticals
12/07/2006	16h18	Business Wire	Kos Submits Supplemental New Drug Application To FDA For New Niaspan(R) CF Range of Products	NASDAQ:KOSP	Kos Pharmaceuticals
20/06/2006	08h00	Business Wire	Niaspan(R) Combined with Low/Moderate Dosed Statin Achieves Better Total Lipid Control vs. Higher Dose Statin Monotherapy or Zo	NASDAQ:KOSP	Kos Pharmaceuticals
07/06/2006	15h42	Business Wire	Kos Announces Completion of Patient Randomization for Jerini's Phase III Clinical Trials of Icatibant for the Subcutaneous Trea	NASDAQ:KOSP	Kos Pharmaceuticals
09/05/2006	13h00	Business Wire	Kos Reports Continued Double Digit Increase in Revenue, Financial Results in Line with Guidance and Authorization for up to 7 M	NASDAQ:KOSP	Kos Pharmaceuticals
08/05/2006	14h00	PR Newswire (US)	SkyePharma and Kos to Host Teleconference Today on US Marketing and Distribution Agreement for Flutiform(TM)	NASDAQ:KOSP
08/05/2006	09h00	PR Newswire (US)	SkyePharma and Kos Announce Exclusive Licence Agreement for Marketing and Distribution of Flutiform(TM) in the United States	NASDAQ:KOSP	Kos Pharmaceuticals
05/05/2006	16h51	Business Wire	CORRECTING and REPLACING Kos Announces Presentation at the Bank of America 2006 Healthcare Conference	NASDAQ:KOSP	Kos Pharmaceuticals
05/05/2006	14h30	Business Wire	Kos Announces Presentation at the Bank of America 2006 Healthcare Conference	NASDAQ:KOSP	Kos Pharmaceuticals
25/04/2006	19h09	Business Wire	Kos Announces Presentation at the Deutsche Bank 2006 Healthcare Conference	NASDAQ:KOSP	Kos Pharmaceuticals
24/04/2006	23h06	Business Wire	Kos Pharmaceuticals to Report First Quarter Results on May 9, 2006 Conference Call at 8:30 A.M. ET	NASDAQ:KOSP	Kos Pharmaceuticals
19/04/2006	16h25	Business Wire	Kos Announces Annual Shareholders Meeting April 27, 2006	NASDAQ:KOSP	Kos Pharmaceuticals
12/04/2006	20h51	Business Wire	Centers for Medicare and Medicaid Services (CMS) Advises Plans Niaspan(R) is Now a Part D Eligible Drug; Confirms Niaspan as an	NASDAQ:KOSP	Kos Pharmaceuticals
01/03/2006	14h36	Business Wire	Kos Announces Presentation at the Lehman Brothers Ninth Annual Global Healthcare Conference	NASDAQ:KOSP	Kos Pharmaceuticals
28/02/2006	14h52	Business Wire	Kos Announces Presentation at the SG Cowen 26th Annual Health Care Conference	NASDAQ:KOSP	Kos Pharmaceuticals

Showing the most relevant articles for your search:NASDAQ:KOSP

1 2 3 Next >>

Oxford Square Capital

BNP Paribas Issuance

Guaranty Financial (CE)

Denali Structured Return...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen